BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Zomedica Announces Achievement of Therapeutic Development Milestones

  ZM-012 and ZM-007 are complementary oral formulations of metronidazole targeting the treatment of acute diarrhea in dogs

  December 12, 2017

   · 

  7 min read
• Deals

  Genetic Technologies Provides Update on Strategic Review Initiative

  The company has entered an important stage of the Company’s strategic review which was announced to the market on 25 August 2017.

  December 12, 2017

   · 

  4 min read
• Business

  PsiOxus Therapeutics Receives $15M Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA

  Under the terms of the December 2016 agreement, Bristol-Myers Squibb granted PsiOxus an upfront payment of $50 million.

  December 12, 2017

   · 

  3 min read
• Business

  Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as CMO

  Dr. Kelley will assumes responsibility for all medical matters at Flexion, including Medical Affairs, Clinical Research and Clinical Operations.

  December 12, 2017

   · 

  3 min read
• Drug Development

  Aptose Presents New Preclinical Data on CG’806 pan-FLT3/pan-BTK Inhibitor at ASH 59th Annual Meeting

  Data elucidate unique ability of CG’806 to kill a broad range of AML cells by suppressing multiple pathways, to overcome resistance caused by bone marrow stromal cells, and to act synergistically with other agents.

  December 12, 2017

   · 

  7 min read
• BRAIN AG and Mannheim University of Applied Sciences Jointly Develop 3D Skin Models for Health Care and Cosmetics

  As the first milestone of the project, the research partners HS Mannheim and BRAIN have published a review article entitled “in Vitro Skin Three-Dimensional Models and Their Applications” in the Journal of Cellular Biotechnology.

  December 12, 2017

   · 

  5 min read
• Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round

  Shareholders have until Sunday, December 24th, 2017, at 3:00pm IST to vote their acceptance of the offer.

  December 12, 2017

   · 

  3 min read
• Deals

  Jupiter Life Sciences Consulting Acquires Alta Bioscience Consulting

  The acquisition supports Jupiter’s rapid geographic expansion and grows its practice areas and payer network in the pharma and biotech industry.

  December 12, 2017

   · 

  2 min read
• Drug Development

  Actinium Pharmaceuticals Highlights Data at the American Society of Hematology Annual Meeting Showing CD33 Expression in a Significant Number of Multiple Myeloma Patients Supporting the Rationale for Actimab-M

  Actinium is the first and only company thus far to have a CD33 targeted therapy for multiple myeloma and the results from this analysis provide further rationale for the Company’s myeloma initiative.

  December 12, 2017

   · 

  5 min read
• Business

  Scythian Biosciences Corp. Announces Appointment of Ottis Anderson to Pro Athlete Advisory Committee

  The Company has also issued an additional 8,750 stock options with an exercise price of $8.65 per share for a period of five years, as well as 56,250 deferred share units to officers of the Company.

  December 12, 2017

   · 

  4 min read